Physicochemical and Toxicological Properties of Particles Emitted from Scalmalloy During the LPBF Process.

Nikoletta Sargioti, Leonidas Karavias, Leonidas Gargalis, Anna Karatza, Elias P Koumoulos, Evangelia K Karaxi

Abstract read

In one paragraph

Article in Toxics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nikoletta SargiotiConify, P. Nikolaidi 23A, Agios Ioannis Rentis, 182 33 Athens, Greece.ORCID 0009-0006-2332-1802

Leonidas KaraviasConify, P. Nikolaidi 23A, Agios Ioannis Rentis, 182 33 Athens, Greece.ORCID 0009-0000-2647-8473

Leonidas GargalisConify, P. Nikolaidi 23A, Agios Ioannis Rentis, 182 33 Athens, Greece.ORCID 0000-0003-4551-4403

Anna KaratzaBioG3D, P.C., P. Nikolaidi 23A, Agios Ioannis Rentis, 182 33 Athens, Greece.ORCID 0000-0001-8385-8050

Elias P KoumoulosIRES-Innovation in Research & Engineering Solutions, Silversquare Europe Square de Meeûs 35, 1000 Brussels, Belgium.ORCID 0000-0002-7875-7324

Evangelia K KaraxiConify, P. Nikolaidi 23A, Agios Ioannis Rentis, 182 33 Athens, Greece.ORCID 0000-0003-4828-0016

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the physicochemical and toxicological properties of Scalmalloy powder emissions generated during Laser Powder Bed Fusion (LPBF), focusing on the impact of particle morphology, oxidation, and size distribution on biological responses. Scanning Electron Microscopy (SEM) and Energy Dispersive Spectroscopy (EDS) analyses revealed significant variations in particle characteristics, with the highest oxidation levels and irregular morphologies observed in exhaust-derived powders. In vitro cytotoxicity evaluations using A549 lung epithelial cells showed significant reductions in cell viability (~60 to 69%) and increased oxidative stress (

Indexed as

cell viabilitylaser powder bed fusion (LPBF)oxidative stressparticle morphologyScalmalloy

Identifiers

PMID40423477

DOI10.3390/toxics13050398

PMCPMC12116082

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.